Crossref
journal-article
Elsevier BV
Trends in Pharmacological Sciences (78)
References
72
Referenced
264
10.1016/S0165-6147(00)89032-X
/ Trends Pharmacol. Sci. / Agonist-receptor efficacy II: agonist-trafficking of receptor signals by Kenakin (1995)10.1146/annurev.pharmtox.42.091401.113012
/ Annu. Rev. Pharmacol. Toxicol. / Efficacy at G protein coupled receptors by Kenakin (2002)10.1038/nrd722
/ Nat. Rev. Drug Discov. / Efficacy at G protein coupled receptors by Kenakin (2002)10.1074/jbc.C100162200
/ J. Biol. Chem. / Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta(2) adrenergic receptor by Ghanouni (2001)10.1002/(SICI)1097-0134(199702)27:2<171::AID-PROT3>3.0.CO;2-J
/ Proteins / Predicting the equilibrium protein folding pathway: structure-based analysis of staphylococcal nuclease by Hilser (1997)10.1073/pnas.95.17.9903
/ Proc. Natl. Acad. Sci. U. S. A. / The structural distribution of cooperative interactions in proteins: analysis of the native state ensemble by Hilser (1998)10.1007/BF00421225
/ Mol. Cell. Biochem. / Hydrogen exchange and the dynamic structure of proteins by Woodward (1982)10.1016/0968-0004(93)90086-3
/ Trends Biochem. Sci. / Is the slow-exchange core the protein folding core? by Woodward (1993)10.1016/S0021-9258(18)45962-5
/ J. Biol. Chem. / Constitutive activation of the α1B-adrenergic receptor by all amino acid substitutions at a single site by Kjelsberg (1992)10.1016/S0021-9258(18)53442-6
/ J. Biol. Chem. / A mutation-induced activated state of the β2-adrenergic receptor: extending the ternary complex model by Samama (1993)10.1006/jtbi.1996.0014
/ J. Theor. Biol. / The cubic ternary complex receptor-occupancy model. I. Model description by Weiss (1996)10.1006/jtbi.1996.0015
/ J. Theor. Biol. / The cubic ternary complex receptor-occupancy model. II. Understanding apparent affinity by Weiss (1996)10.1006/jtbi.1996.0139
/ J. Theor. Biol. / The cubic ternary complex receptor-occupancy model. III. Resurrecting efficacy by Weiss (1996){'key': '10.1016/S0165-6147(03)00167-6_BIB14', 'first-page': '2723', 'article-title': 'Conformational changes and drug action', 'volume': '40', 'author': 'Burgen', 'year': '1966', 'journal-title': 'Fed. Proc.'}
/ Fed. Proc. / Conformational changes and drug action by Burgen (1966)10.1016/0165-6147(96)20026-4
/ Trends Pharmacol. Sci. / Receptor conformational induction vs. selection: all part of the same energy landscape by Kenakin (1996)10.1124/mol.58.6.1230
/ Mol. Pharmacol. / The use of stimulus-biased assay systems to detect agonist-specific receptor active states: implications for the trafficking of receptor stimulus by agonists by Watson (2000)10.1042/0264-6021:3420071
/ Biochem. J. / Differential G-protein activation by alkaloid and peptide agonists in the human neuroblastoma cell line SKE-N-BE by Allouche (1999)10.1111/j.1749-6632.1997.tb48151.x
/ Ann. N. Y. Acad. Sci. / Protean agonists: keys to receptor active state? by Kenakin (1997)10.1046/j.1471-4159.1999.0730281.x
/ J. Neurochem. / The cholecystokinB receptor is coupled to two effector pathways through pertussis toxin-sensitive and –insensitive G proteins by Pommier (1999){'key': '10.1016/S0165-6147(03)00167-6_BIB20', 'first-page': '379', 'article-title': 'A modification of receptor theory', 'volume': '11', 'author': 'Stephenson', 'year': '1956', 'journal-title': 'Br. J. Pharmacol.'}
/ Br. J. Pharmacol. / A modification of receptor theory by Stephenson (1956)10.1016/S0898-6568(01)00239-X
/ Cell. Signal. / G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction by Brady (2002)10.1096/fj.00-0438rev
/ FASEB J. / Inverse, protean, and ligand-selective agonism: matters of receptor conformation by Kenakin (2001)10.1091/mbc.01-03-0129
/ Mol. Biol. Cell / Multiple active states and oligermization of CCR5 revealed by functional properties of monoclonal antibodies by Blanpain (2002)10.1124/pr.54.2.323
/ Pharmacol. Rev. / G-protein coupled receptor allosterism and complexing by Christopoulos (2002)10.1074/jbc.270.47.28268
/ J. Biol. Chem. / Fluorescent labeling of purified β2-adrenergic receptor: evidence for ligand specific conformational changes by Gether (1995)10.1073/pnas.96.10.5698
/ Proc. Natl. Acad. Sci. U. S. A. / A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity by Baba (1999)10.1016/S0960-894X(01)00492-9
/ Bioorg. Med. Chem. Lett. / Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure–Activity relationships for 1-[N-(Methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes by Finke (2001)10.1073/pnas.221375398
/ Proc. Natl. Acad. Sci. U. S. A. / SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo by Strizki (2001)10.1016/S1074-5521(96)90126-X
/ Chem. Biol. / Chemokine receptors-the new frontier for aids research by Wells (1996)10.1074/jbc.M009772200
/ J. Biol. Chem. / Bombesin and substance P analogues differentially regulate G-protein coupling to the bombesin receptor by MacKinnon (2001)10.1021/bi990437n
/ Biochemistry / Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via type 1 PTH receptor: Implications for design of signal-specific PTH ligands by Takasu (1999){'key': '10.1016/S0165-6147(03)00167-6_BIB32', 'first-page': '20', 'article-title': 'Agonist selective receptor states: the new level of selectivity?', 'volume': '5', 'author': 'Kenakin', 'year': '1998', 'journal-title': 'Pharm. News'}
/ Pharm. News / Agonist selective receptor states: the new level of selectivity? by Kenakin (1998)10.1124/mol.61.1.85
/ Mol. Pharmacol. / Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Gαs- and Gαi/o-proteins by Pindon (2002)10.1016/S0165-6147(02)02046-1
/ Trends Pharmacol. Sci. / Recombinant roulette versus the apparent virtues of ‘natural’ cell receptor systems: receptor genotypes vs phenotypes by Kenakin (2002)10.1038/365170a0
/ Nature / Differential signal transduction by five splice variants of the PACAP receptor by Spengler (1993){'key': '10.1016/S0165-6147(03)00167-6_BIB36', 'first-page': '1596', 'article-title': 'Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino- terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states', 'volume': '50', 'author': 'Rampelbergh', 'year': '1996', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. / Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino- terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states by Rampelbergh (1996){'key': '10.1016/S0165-6147(03)00167-6_BIB37', 'first-page': '462', 'article-title': 'Comparative effects of receptor inactivation, 17β-estradiol and pertussis toxin on dopaminergic inhibition of prolactin-secretion in vitro', 'volume': '263', 'author': 'Meller', 'year': '1992', 'journal-title': 'J. Pharmacol. Exp. Ther.'}
/ J. Pharmacol. Exp. Ther. / Comparative effects of receptor inactivation, 17β-estradiol and pertussis toxin on dopaminergic inhibition of prolactin-secretion in vitro by Meller (1992)10.1124/jpet.301.3.1166
/ J. Pharmacol. Exp. Ther. / Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D-1 receptors linked to adenylate cyclase by Mottola (2002)10.1002/j.1460-2075.1994.tb06385.x
/ EMBO J. / Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems by Robb (1994)10.1074/jbc.274.34.23770
/ J. Biol. Chem. / Further delineation of the two binding sites (R*n) associated with tachykinin neurokinin-1 receptors using [3-prolinomethionine11]SP analogues by Sagan (1999)10.1124/mol.58.5.954
/ Mol. Pharmacol. / Molecular analysis of β2-adrenoceptor coupling to Gs-, Gi-, and Gq- proteins by Wenzel-Seifert (2000)10.1038/sj.bjp.0703892
/ Br. J. Pharmacol. / Gq/11 and Gi/1o activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: Dependence on agonist as well as receptor-subtype by Akam (2001)10.1124/mol.58.5.1075
/ Mol. Pharmacol. / Influence of receptor number on funcitonal responses elicited by agonists acting at the human adenosine A1 receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity by Cordeaux (2000)10.1038/sj.bjp.0703964
/ Br. J. Pharmacol. / Agonist trafficking of Gi/o-mediated α2A-adrenoceptor responses in HEL 92.1.7 cells by Kukkonen (2001)10.1074/jbc.M009772200
/ J. Biol. Chem. / Bombesin and substance P analogues differentially regulate G-protein coupling to the bombesin receptor by MacKinnon (2001){'key': '10.1016/S0165-6147(03)00167-6_BIB46', 'first-page': '690', 'article-title': 'Multiple conformations of native and recombinant human 5-hydroxytryptamine2A receptors are labeled by agonists and discriminated by antagonists', 'volume': '60', 'author': 'Lopez-Gimenez', 'year': '2001', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. / Multiple conformations of native and recombinant human 5-hydroxytryptamine2A receptors are labeled by agonists and discriminated by antagonists by Lopez-Gimenez (2001){'key': '10.1016/S0165-6147(03)00167-6_BIB47', 'first-page': '884', 'article-title': 'Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular process', 'volume': '287', 'author': 'Bonhaus', 'year': '1998', 'journal-title': 'J. Pharmacol. Exp. Ther.'}
/ J. Pharmacol. Exp. Ther. / Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular process by Bonhaus (1998)10.1038/sj.bjp.0702329
/ Br. J. Pharmacol. / Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPS binding induced by IL-8 and GROα by Hall (1999)10.1124/mol.54.1.94
/ Mol. Pharmacol. / Effect pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus by Berg (1998)10.1124/jpet.102.042184
/ J. Pharmacol. Exp. Ther. / Serotonin 5-hydroxytryptamine (2A) receptor-coupled phospholipase C and phospholipase(A2) signaling pathways have different receptor reserves by Kurrasch-Orbaugh (2003){'key': '10.1016/S0165-6147(03)00167-6_BIB51', 'first-page': '490', 'article-title': 'Inverse agonist activity of β-adrenergic antagonists', 'volume': '45', 'author': 'Chidiac', 'year': '1994', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. / Inverse agonist activity of β-adrenergic antagonists by Chidiac (1994){'key': '10.1016/S0165-6147(03)00167-6_BIB52', 'first-page': '662', 'article-title': 'Agonist-induced modulation of inverse agonist efficacy at the β2-adrenergic receptor', 'volume': '50', 'author': 'Chidiac', 'year': '1996', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. / Agonist-induced modulation of inverse agonist efficacy at the β2-adrenergic receptor by Chidiac (1996){'key': '10.1016/S0165-6147(03)00167-6_BIB53', 'first-page': '963', 'article-title': 'Protean agonism at α2A-adrenoceptors', 'volume': '53', 'author': 'Jansson', 'year': '1998', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. / Protean agonism at α2A-adrenoceptors by Jansson (1998)10.1016/S0028-3908(01)00201-5
/ Neurophamacology / Evidence for protean agonism of RX 831003 at a2A-adrenoceptors by co-expression with different Ga protein subunits by Pauwells (2002)10.1074/jbc.274.42.29603
/ J. Biol. Chem. / Spontaneous human B2 bradykinin receptor activity determines the action of partial agonists as agonists or inverse agonists by Fathy (1999)10.1124/mol.56.3.485
/ Mol. Pharmacol. / Spontaneous β2-adrenergic signaling fails to modulate L-type Ca2+ current in mouse venturicular myocytes by Zhou (1999)10.1124/mol.54.2.435
/ Mol. Pharmacol. / Contribution of serine residues to constitutive and agonist-induced signaling via the D2s dopamine receptor: evidence for multiple, agonist-specific active conformations by Wiens (1998)10.1074/jbc.M106104200
/ J. Biol. Chem. / Constitutively active μ-opioid receptors inhibit adenylyl cyclase activity in intact cells and activate G-proteins differently than the agonist [D-Ala2,N-MePhe4, Gly-ol5]enkephalin by Liu (2001)10.1016/S1056-8719(98)00035-5
/ J. Pharmacol. Toxicol. Meth. / Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer by Dunlop (1999){'key': '10.1016/S0165-6147(03)00167-6_BIB60', 'first-page': '923', 'article-title': 'Aryloxypropanolamine and catecholamine ligand interactions with the β1-adrenergic receptor: evidence for interaction with distinct conformations of β1-adrenergic receptors', 'volume': '294', 'author': 'Konkar', 'year': '2000', 'journal-title': 'J. Pharmacol. Exp. Ther.'}
/ J. Pharmacol. Exp. Ther. / Aryloxypropanolamine and catecholamine ligand interactions with the β1-adrenergic receptor: evidence for interaction with distinct conformations of β1-adrenergic receptors by Konkar (2000){'key': '10.1016/S0165-6147(03)00167-6_BIB61', 'first-page': '357', 'article-title': 'Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor', 'volume': '51', 'author': 'Roettger', 'year': '1997', 'journal-title': 'Mol. Pharmacol.'}
/ Mol. Pharmacol. / Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor by Roettger (1997)10.1074/jbc.271.32.19021
/ J. Biol. Chem. / Morphine activates opioid receptors without causing their rapid internalization by Keith (1996)10.1016/S0021-9258(17)31462-X
/ J. Biol. Chem. / Independence of type I angiotensin II receptor endocytosis from G protein coupling and signal transduction by Hunyady (1994)10.4049/jimmunol.163.6.3037
/ J. Immunol. / Characterization of RANTES- and Aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G-protein-coupled receptor complex by Vila-Coro (1999)10.1084/jem.187.8.1215
/ J. Exp. Med. / Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity by Mack (1998)10.1074/jbc.M202544200
/ J. Biol. Chem. / Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations by Bisello (2002)10.1074/jbc.275.4.2893
/ J. Biol. Chem. / Agonist-induced phosphorylation of the angiotensin II (AT1A) receptor requires generation of a conformation that is distinct from the inositol phosphate-signaling state by Thomas (2000)10.1046/j.1471-4159.1998.71010231.x
/ J. Neurochem. / Distinct differences between morphine- and [δ-Ala2,N-MePhe4,Gly-ol5]enkephalin-mu-opioid complexes demonstrated by cyclic independent protein kinase phosphorylation by Chakrabarti (1998)10.1074/jbc.272.2.782
/ J. Biol. Chem. / Differential opioid agonist regulation of the mouse μ opioid receptor by Blake (1997)10.1111/j.1476-5381.1996.tb15269.x
/ Br. J. Pharmacol. / Selection of distinct conformational states of the 5-HT3 receptor by full and partial agonists by van Hooft (1996)10.1124/mol.52.1.144
/ Mol. Pharmacol. / The stability of the agonist β2-adrenergic receptor-Gs complex: evidence for agonist-specific states by Krumins (1997)10.1124/mol.56.2.348
/ Mol. Pharmacol. / Effects of guanine, inosine, and xanthine nucleotides on β2-adrenergic receptor/Gs interactions: evidence for multiple receptor conformations by Seifert (1999)
Dates
Type | When |
---|---|
Created | 22 years, 2 months ago (June 30, 2003, 2:58 p.m.) |
Deposited | 2 years, 4 months ago (April 26, 2023, 12:32 p.m.) |
Indexed | 1 year, 1 month ago (July 30, 2024, 1:12 a.m.) |
Issued | 22 years, 2 months ago (July 1, 2003) |
Published | 22 years, 2 months ago (July 1, 2003) |
Published Print | 22 years, 2 months ago (July 1, 2003) |
@article{Kenakin_2003, title={Ligand-selective receptor conformations revisited: the promise and the problem}, volume={24}, ISSN={0165-6147}, url={http://dx.doi.org/10.1016/s0165-6147(03)00167-6}, DOI={10.1016/s0165-6147(03)00167-6}, number={7}, journal={Trends in Pharmacological Sciences}, publisher={Elsevier BV}, author={Kenakin, Terry}, year={2003}, month=jul, pages={346–354} }